New Injection Gives Flat-Faced Dogs Easier Breathing

Pugs and bulldogs might finally catch a break from the breathing problems humans bred into them over 150 years ago.

Australian scientists at RMIT University partnered with biotechnology company Snoretox to develop an injection that dramatically improves breathing in flat-faced dog breeds. The treatment targets a chronic condition affecting nine out of 10 pugs, French bulldogs, and English bulldogs.

The problem stems from selective breeding in the mid-1800s that gave these breeds their signature squished faces. Their shortened skulls created a serious issue: too much soft tissue crowded into too little space, blocking their airways from birth.

This condition, called brachycephalic obstructive airway syndrome (BOAS), makes simple activities like walking or playing exhausting and sometimes dangerous. Dogs with severe BOAS pant until they vomit from excitement, struggle to regulate their body temperature, and can die up to four years earlier than they should.

The new treatment, called Snoretox-1, uses a modified tetanus toxin to strengthen muscles in the floor of the mouth. These stronger muscles naturally hold airways open, relieving the constriction caused by excess throat tissue.

The early results are remarkable. Six bulldogs with severe BOAS couldn't complete a three-minute walk before treatment. After receiving Snoretox-1, all six finished the walk faster and with noticeably quieter, easier breathing.

Professor Tony Sasse, Snoretox managing director and RMIT researcher, highlighted another benefit: the injection helped dogs who hadn't improved after surgery. The team spent 15 years developing this minimally invasive alternative to risky surgical procedures.

Why This Inspires

This breakthrough represents more than veterinary innovation. It shows scientists taking responsibility for fixing problems humans created through careless breeding practices.

The treatment offers hope to millions of pet owners watching their beloved companions struggle with every breath. One treated bulldog named Pugtato showed such dramatic improvement that the before-and-after comparison shocked even the researchers.

Beyond individual pets, this injection could reshape how we approach breed-related health problems. Professor Peter Smooker notes the therapy might eventually help other animals and conditions, though the team is currently focused on getting Snoretox-1 approved for widespread use in dogs.

The path forward requires additional research and regulatory approval, but the initial success gives both scientists and struggling pets reason to breathe easier.